Respiratory health is one of the most pressing healthcare challenges of our time. Conditions such as asthma, chronic obstructive pulmonary disease (COPD), and allergic respiratory disorders continue to affect millions of people worldwide. Managing these conditions effectively requires not only clinical expertise but also reliable pharmaceutical ingredients that form the backbone of advanced therapies.

At Coral Drugs, we are committed to supporting respiratory wellness through our cGMP-grade Active Pharmaceutical Ingredients (APIs) that are widely trusted by global pharmaceutical partners. With a strong focus on quality, compliance, and innovation, we deliver APIs that empower the development of inhalation therapies designed to improve breathing, reduce inflammation, and enhance quality of life for patients.

Supporting Long-Term Respiratory Care

Respiratory illnesses often result in both short-term symptoms and long-term damage. Patients may experience coughing, wheezing, or difficulty in breathing in the short run, while prolonged conditions can lead to chronic lung impairment and reduced recovery capacity. Pharmaceutical interventions play a crucial role in addressing these challenges, and Coral Drugs provides the essential building blocks for such therapies.

APIs for Asthma and COPD Management

Asthma and COPD are two of the most widespread respiratory conditions that require continuous care. Coral Drugs manufactures cGMP-grade corticosteroid APIs such as:

Beclomethasone Dipropionate

Budesonide

Ciclesonide

Fluticasone Propionate / Furoate

Mometasone Furoate (Anhydrous & Monohydrate)

These APIs are specifically used in targeted inhalation therapies. They work by reducing airway inflammation, helping patients maintain better lung function and breathe more comfortably.

APIs for Symptom Relief

Beyond chronic conditions, respiratory discomfort can also arise from allergies and seasonal triggers. To ease such symptoms, Coral Drugs provides APIs for bronchodilators and antihistamines, including:

Formoterol Fumarate Dihydrate

Salmeterol Xinafoate

Azelastine Hydrochloride

These compounds relax airway muscles and control allergic responses, ensuring relief and improved breathing for patients across a variety of conditions.

Global Quality and Compliance

Coral Drugs stands out as a trusted respiratory API partner by ensuring backward-integrated manufacturing, scalable production capacity, and strict adherence to international quality standards. This enables our partners to rely on us for consistent supply, regulatory compliance, and long-term collaboration in developing critical respiratory therapies.

A Partner for a Healthier Future

By enabling pharmaceutical companies with high-quality APIs, Coral Drugs contributes to global efforts in combating respiratory diseases and enhancing patient well-being. Whether addressing chronic conditions like asthma and COPD or providing relief from allergy-related symptoms, our APIs are trusted worldwide for their efficacy, safety, and compliance.

Respiratory wellness is not just a healthcare priority—it is a shared responsibility. At Coral Drugs, we are proud to play our part in advancing treatments that help people breathe easier and live healthier lives.

Explore more about Coral Drugs’ innovations and respiratory APIs by following us on LinkedIn 

‍